SCHEMBL19967295

SCHEMBL19967295

CCc1cc(F)c(-c2c(Cl)nn(C)c2-c2ccc(C)cc2)c(F)c1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.34
CRHR1 P34998 1/20 0.34
SLC34A1 Q06495 5/20 0.33
SMN1; SMN2 Q16637 4/20 0.33
TDP1 Q9NUW8 2/20 0.33
L3MBTL1 Q9Y468 3/20 0.33
RAB9A P51151 2/20 0.33
DUSP3 P51452 1/20 0.33
MEN1 O00255 2/20 0.32
MAPT P10636 1/20 0.32
BRD9 Q9H8M2 1/20 0.32
PGR P06401 1/20 0.31
NR3C2 P08235 1/20 0.31
RIPK3 Q9Y572 1/20 0.31
NPC1 O15118 1/20 0.31
KDM4E B2RXH2 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP3A4 P08684 1/20 0.31
GAA P10253 1/20 0.31
CYP2C9 P11712 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1025606 0.77 GRM5 (0.38) CRHR1SLC34A1MAPT
SCHEMBL19967170 0.77 PDE2A (0.41) KMT2ACRHR1SLC34A1MEN1MAPT
SCHEMBL19353716 0.74 HEXA (0.39) KMT2AMAPTCYP1A2
SCHEMBL1023884 0.73 CYP1A2 (0.38) KMT2ACRHR1TDP1MEN1MAPT
SCHEMBL1023890 0.70 MEN1 (0.36) KMT2ASLC34A1MEN1CYP3A4CYP2C9
SCHEMBL14996540 0.69 L3MBTL1 (0.44) KMT2ASLC34A1TDP1L3MBTL1MAPT
SCHEMBL1027586 0.68 GRM8 (0.36) CYP1A2
SCHEMBL1023290 0.68 NR1H2 (0.36) CRHR1
SCHEMBL1025914 0.66 PDE10A (0.32)
SCHEMBL1025108 0.65 PDE10A (0.37) SLC34A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018048969-A1 MULTI-TARGETED HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2018-03-15 WO disclosed